07:00 , May 25, 2015 |  BC Week In Review  |  Company News

Roche, Astellas deal

Roche’s Ventana Medical Systems Inc. unit will develop companion diagnostics for compounds being developed by Astellas, including the pharma’s ASP5878 . The fibroblast growth factor (FGF) receptor (FGFR) inhibitor is in Phase I testing to...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Company News

Qiagen, Astellas deal

The companies to develop and commercialize companion diagnostics for Astellas’ pipeline. Qiagen develops assays based on PCR, next-generation sequencing and multi-modal testing technologies using liquid and tissue biopsies. The deal will initially focus on Astellas’...